Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow In Endocrinology, Medicine, Vanderbilt University 2006 - 2009
  • Resident, Medicine, Virginia Commonwealth University 2003 - 2006
  • M.D., Dartmouth College 2003
• 

  Duke Appointment History

  • Assistant Professor of Medicine, Medicine, Endocrinology, Metabolism, and Nutrition, Medicine 2009 - 2016
• Research
• 

  Selected Grants

  • Clinically vs. pathologically negative lymph nodes in patients with papillary thyroid cancer  awarded by Endocrine Fellows Foundation 2015 - 2016
• Publications & Artistic Works
• 

  Selected Publications

  • Journal Articles

    • Ruel, E, Thomas, S, Perkins, JM, Roman, SA, and Sosa, JA. "The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer." Annals of surgical oncology 24, no. 7 (July 2017): 1935-1942.  Full Text
    • Joy, NG, Perkins, JM, Mikeladze, M, Younk, L, Tate, DB, and Davis, SN. "Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans." Journal of diabetes and its complications 30, no. 7 (September 2016): 1275-1281.  Full Text
    • Ruel, E, Thomas, S, Dinan, MA, Perkins, JM, Roman, SA, and Sosa, JA. "Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer." Endocrine 52, no. 3 (June 2016): 579-586.  Full Text
    • Perkins, JM, Joy, NG, Tate, DB, and Davis, SN. "Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans." American journal of physiology. Endocrinology and metabolism 309, no. 2 (July 2015): E168-E176.  Full Text
    • Ruel, E, Thomas, S, Dinan, M, Perkins, JM, Roman, SA, and Sosa, JA. "Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer." The Journal of Clinical Endocrinology and Metabolism 100, no. 4 (April 2015): 1529-1536.  Full Text
    • Bohinc, BN, and Perkins, JM. "Appropriate dosing of adjuvant radioactive iodine for differentiated thyroid cancer." Curr Opin Oncol 26, no. 1 (January 2014): 31-35. (Review)  Full Text  Link to Item
    • Dunn, JP, Perkins, JM, and Jagasia, SM. "Case study: Latent autoimmune diabetes in adults and pregnancy: Foretelling the future." Clinical Diabetes 26, no. 1 (2008): 44-46.  Full Text
    • Perkins, JM, and Davis, SN. "Endocannabinoid system overactivity and the metabolic syndrome: Prospects for treatment." Current Diabetes Reports 8, no. 1 (2008): 12-19.  Full Text
    • Perkins, JM, and Davis, SN. "The renin-angiotensin-aldosterone system: A pivotal role in insulin sensitivity and glycemic control." Current Opinion in Endocrinology, Diabetes and Obesity 15, no. 2 (2008): 147-152.  Full Text
    • Davis, SN, and Perkins, JM. "Role of the endocannabinoid system in management of patients with type 2 diabetes mellitus and cardiovascular risk factors." Endocrine Practice 13, no. 7 (2007): 790-804.
    • Perkins, JM, Dunn, JP, and Jagasia, SM. "Perspectives in gestational diabetes mellitus: A review of screening, diagnosis, and treatment." Clinical Diabetes 25, no. 2 (2007): 57-62.  Full Text
    • Perkins, JM, and Davis, SN. "The Rationale for Prandial Glycemic Control in Diabetes Mellitus." Insulin 2, no. 2 (2007): 52-60.  Full Text

  • Other Articles

    • Goffredo, P, Thomas, SM, Dinan, MA, Perkins, JM, Roman, SA, and Sosa, JA. "Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse." JAMA internal medicine 175, no. 4 (April 2015): 638-640.  Full Text
• Teaching & Mentoring
• 

  Recent Courses

  • EPH 301B: RESEARCH IN EPI & PUBLIC HEALTH 2017

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.